WARRANT LIABILITY |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Reconciliation Of Credit Line Warrant Liability | ||||||||||||||||||||||||||||||||||||||||||||||
| WARRANT LIABILITY | NOTE 9 – WARRANT LIABILITY
On December 5, 2024, the Company entered into an Equity Line of Credit Agreement with Mast Hill Fund, L.P. (the “Investor”), pursuant to which the Investor committed to provide up to $5.0 million to the Company.
In connection with the agreement, the Company issued a purchase warrant to the Investor to purchase up to 33,333 shares of common stock at an initial exercise price of $30 per share (number of shares and exercise price are retroactively adjusted to reflect the 1-for-15 reverse stock split effective October 6, 2025 — see Note 2), subject to customary anti-dilution adjustments and a 4.99% beneficial ownership limitation. The warrant is exercising upon issuance and expires on the second anniversary of the issuance date.
The warrant contains a down-round provision whereby the exercise price will be reduced if the Company issues common stock, options, or convertible securities at a price below the then-current exercise price of the warrant.
The warrant was classified as a liability and initially recorded at fair value of $104,744 upon issuance. As of December 31, 2025, the fair value of the warrant liability was remeasured to $20,474. The Company recognized a gain from the change in fair value of warrant liability of $57,674 and $26,596 for the years ended December 31, 2025 and 2024.
The following table presents a reconciliation of the credit line warrant liability measured and recorded at fair value on a recurring basis:
|
|||||||||||||||||||||||||||||||||||||||||||||